Uncovering the underlying causes of Parkinson's disease

April 3, 2014 by Angelo Risso
Recreation of dopamine (purple) and iron (teal) distribution in the mouse midbrain. Credit: Ethix Design

(Medical Xpress)—A breakthrough investigation by UTS researchers into the underlying causes of Parkinson's disease has brought us a step closer to understanding how to manage the condition.

The team, led by UTS postdoctoral fellow Dr Dominic Hare and Professor Philip Doble, has produced the first empirical evidence that an imbalance of and dopamine in the substantia nigra pars compacta (SNc) region of the is the root cause of the neurodegenerative condition.

Caused by the slow loss of neurons in the SNc that control autonomous movement, Parkinson's disease causes persistent shaking, gastrointestinal problems and a variety of other ailments.

More than 80,000 Australians suffer from the illness, most over the age of 60.

Hare's findings, before only assumptions in the scientific community, finally validate the theory that iron and dopamine react to create free radicals in the brain that slowly destroy neuron pathways and bring about the onset of Parkinson's.

"When these two chemicals react, it forms a toxic species of dopamine that essentially reacts like bleach in the brain," said Hare.

To conduct their research Hare and his team used a unique tagging technique using antibodies labelled with gold nanoparticles that acted as proxies for dopamine molecules. This enabled the team to monitor and "co-localise" metals with other molecules and proteins in the brain.

And the findings of this work, said Hare, were revelatory.

Dominic Hare. Credit: Carmen Lee Spiers

"What we found is those particular cells (in the SNc) have what you could call an 'anti-Goldilocks effect' – they have just the right amount of iron and just the right amount of to cause damage," said Dr Hare.

"When we give mice a toxin that mimics the effects of Parkinson's disease, these cells degenerate."

Hare theorises that this effect is likely a natural result of aging, when the brain's ability to securely store iron diminishes and allows iron molecules to "leak" into critical areas such as the SNc.

Finding ways to design drugs that can get into the brain and eliminate surplus iron – an initiative that is already well underway in the process of treating other illnesses like cancer and Alzheimer's disease – is now the next step forward in research.

Preventative measures to halt the build-up of iron in the brain as humans undergo the aging process are also touted by Hare as an important next step, and is something he is now working on.

"I think the real hope is, while we might not necessarily find a cure, prevention is actually not that far away," said Hare.

"So it's a case where you can wake up and say, 'my Parkinson's is flaring up again', take a tablet and go about your business."

Explore further: Using rabies virus, researcher tracks inputs to dopamine neurons

More information: "An iron–dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta." Dominic J. Hare, et al. Chem. Sci., 2014, Advance Article, DOI: 10.1039/C3SC53461H

Related Stories

Using rabies virus, researcher tracks inputs to dopamine neurons

June 6, 2012
A genetically-modified version of the rabies virus is helping scientists at Harvard to trace neural pathways in the brain, a research effort that could one day lead to treatments for Parkinson's disease and addiction.

Ultra-high-field MRI may allow earlier diagnosis of Parkinson's disease

March 5, 2014
New research shows that ultra-high-field magnetic resonance imaging (MRI) provides detailed views of a brain area implicated in Parkinson's disease, possibly leading to earlier detection of a condition that affects millions ...

Stress-induced depression exacerbates Parkinson's

March 6, 2014
(Medical Xpress)—Chronic stress-induced depression exacerbated an experimental model of Parkinson's disease, researchers at the University of Cincinnati (UC) have shown.

'Big Science' uncovers another piece in the Alzheimer's puzzle

March 26, 2014
In a paper published today, British scientists have found evidence that  biological material contributing to lesions in the brain, characteristic in Alzheimer's patients, may also cause the build-up of brain-cell-damaging ...

Recommended for you

Waterlogged brain region helps scientists gauge damage caused by Parkinson's disease

July 26, 2017
Scientists at the University of Florida have discovered a new method of observing the brain changes caused by Parkinson's disease, which destroys neurons important for movement. The development suggests that fluid changes ...

Parkinson's is partly an autoimmune disease, study finds

June 21, 2017
Researchers have found the first direct evidence that autoimmunity—in which the immune system attacks the body's own tissues—plays a role in Parkinson's disease, the neurodegenerative movement disorder. The findings raise ...

Predicting cognitive deficits in people with Parkinson's disease

June 20, 2017
Parkinson's disease (PD) is commonly thought of as a movement disorder, but after years of living with PD approximately twenty five percent of patients also experience deficits in cognition that impair function. A newly developed ...

Pre-clinical study suggests Parkinson's could start in gut endocrine cells

June 15, 2017
Recent research on Parkinson's disease has focused on the gut-brain connection, examining patients' gut bacteria, and even how severing the vagus nerve connecting the stomach and brain might protect some people from the debilitating ...

Hi-res view of protein complex shows how it breaks up protein tangles

June 15, 2017
Misfolded proteins are the culprits behind amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and other neurodegenerative brain disorders. These distorted proteins are unable to perform their normal ...

CRISPR tech leads to new screening tool for Parkinson's disease

June 5, 2017
A team of researchers at the University of Central Florida is using breakthrough gene-editing technology to develop a new screening tool for Parkinson's disease, a debilitating degenerative disorder of the nervous system. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.